Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F C Breedveld

Showing results (11-20 of 501) with videos related to

Pageof 51
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|October 26, 2005
[Tumour necrosis factor antagonists: infliximab, adalimumab and etanercept]F C Breedveld
The Netherlands Journal of Medicine|January 11, 2000
Rheumatology in the 21st centuryF C Breedveld
Rheumatology (Oxford, England)|January 26, 2000
Future trends in the treatment of rheumatoid arthritis: cytokine targetsF C Breedveld
Arthritis Research|November 30, 2000
Immune ablation and stem-cell therapy in autoimmune disease. IntroductionF C Breedveld
Clinical Medicine (London, England)|May 3, 2001
Tumour necrosis factor blockade in rheumatoid arthritisF C Breedveld
Arthritis and Rheumatism|May 1, 1997
Minocycline in rheumatoid arthritisF C Breedveld
The Journal of Rheumatology. Supplement|July 17, 1998
New insights in the pathogenesis of rheumatoid arthritisF C Breedveld
Annals of the Rheumatic Diseases|May 1, 1990
Dutch dispatchA Cats, F C Breedveld
Annals of the Rheumatic Diseases|August 1, 1992
From The NetherlandsA Cats, F C Breedveld
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Analysis of serial synovial biopsies as a screening method for predicting the effects of therapeutic interventionsP P Tak, F C Breedveld
Pageof 51

Showing results (11-20 of 501) with videos related to

Sort By:
Pageof 51
Nederlands Tijdschrift Voor Geneeskunde|October 26, 2005
[Tumour necrosis factor antagonists: infliximab, adalimumab and etanercept]F C Breedveld
The Netherlands Journal of Medicine|January 11, 2000
Rheumatology in the 21st centuryF C Breedveld
Rheumatology (Oxford, England)|January 26, 2000
Future trends in the treatment of rheumatoid arthritis: cytokine targetsF C Breedveld
Arthritis Research|November 30, 2000
Immune ablation and stem-cell therapy in autoimmune disease. IntroductionF C Breedveld
Clinical Medicine (London, England)|May 3, 2001
Tumour necrosis factor blockade in rheumatoid arthritisF C Breedveld
Arthritis and Rheumatism|May 1, 1997
Minocycline in rheumatoid arthritisF C Breedveld
The Journal of Rheumatology. Supplement|July 17, 1998
New insights in the pathogenesis of rheumatoid arthritisF C Breedveld
Annals of the Rheumatic Diseases|May 1, 1990
Dutch dispatchA Cats, F C Breedveld
Annals of the Rheumatic Diseases|August 1, 1992
From The NetherlandsA Cats, F C Breedveld
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Analysis of serial synovial biopsies as a screening method for predicting the effects of therapeutic interventionsP P Tak, F C Breedveld
Pageof 51